C

Citrini

Citrini Research

Insights on thematic equity investing, global macro trading with cross-asset, lateral thinking.

View Research Index
Another_Brick_in_the_Wall_of_Worry_1
October 8, 2024

Another Brick in the Wall of Worry

Annual China Macroeconomic Update

Analytical Frameworks: Evaluating Payments
September 30, 2024

Analytical Frameworks: Evaluating Payments

Sweet Dreams are Made of Fees

Can_You_Hear_Me_Now__1
August 26, 2024

Can You Hear Me Now?

The Coming Optics Shortage & Telecom Suppliers' New Dawn

At CitriniResearch we attempt to highlight and demystify themes that will define the market’s distribution of returns for years to come.

Our Research

We research market themes & narratives to identify the "megatrends".

Analytical Frameworks: Evaluating Payments
September 30, 2024

Analytical Frameworks: Evaluating Payments

Sweet Dreams are Made of Fees

Can_You_Hear_Me_Now__1
August 26, 2024

Can You Hear Me Now?

The Coming Optics Shortage & Telecom Suppliers' New Dawn

Healthcare_s_Cyclical_Inflection_1
August 7, 2024

Healthcare’s Cyclical Inflection

From Life Changing to Life Support…and Back Again

Interconnects_101_1
July 3, 2024

Interconnects 101

Our Intra-Thematic AI Primers on Bits & Bottlenecks

The_Utility_of_Bubbles__The_Intersection_of_Fiscal___AI_1
June 5, 2024

The Utility of Bubbles: The Intersection of Fiscal & AI

The second section from our annual review to be broken out is our commentary the intersection of AI-linked Capex and fiscal spending.

High_Quality_H2O_1
May 7, 2024

High Quality H2O

Thematic Primer: Water’s Secular Tailwinds

Election_2024__Investment_Implications___Preparations_1
March 5, 2024

Election 2024: Investment Implications & Preparations

Expect the Unexpected…Then Expect it Again

24_Trades_for_2024_1
December 21, 2023

24 Trades for 2024

An Outlook

China_at_the_Crossroads_1
August 24, 2023

China at the Crossroads

Minsky Moment or Beautiful Deleveraging?

Upgrading_from_Overweight__The_Effects_of_GLP_1_Drugs_on_the_Investment_Landscape_1
July 11, 2023

Upgrading from Overweight: The Effects of GLP-1 Drugs on the Investment Landscape

Are drugs like Ozempic just a fad or the answer to a problem that the Developed world has been seeking for decades?

Artificial_Intelligence__Global_Equity_Beneficiaries_1
May 31, 2023

Artificial Intelligence: Global Equity Beneficiaries

AI/ML Basket & Trend Analysis

Latest Market Memos

Datanote: September ISM & JOLTS

Market Memo

As part of our August 2024 Macro Memo, we opined...

October 1, 2024

Read More

Macro Memo: August 2024

Market Memo

Our Outlook: Optimistically Paranoid

September 5, 2024

Read More

GLP-1 Check In

Market Memo

LLY +100%, Highlights from Annual Review

June 11, 2024

Read More

Market Memo: The Day After Tomorrow

Market Memo

Rapid Fire Opinions

April 16, 2024

Read More

Retrospective

Retrospective
September 20, 2024

Citrindex Retrospective: Post September FOMC

Performance Updates YTD plus “Food Wars”, Satellites, AirSculpt

retrospective
August 7, 2024

Citrindex Retrospective: July 2024

Changes to our holdings, performance and “Schrodinger’s Soft Landing”

Retrospective
July 2, 2024

Citrini Retrospective: June 2024

A turbulent but resilient month for the Citrindex caps off another quarter of outperformance

Retrospective
June 3, 2024

Annual Review: AI Thematic Highlights

AAPL vs. GOOGL, AI DC Power Demand, NVDA/CRDO/CGNX/TSMC Thoughts

Citrini In Conversation

Citrini&TKNO
October 14, 2024

In Conversation: Alpha Teknova (TKNO US)

Our Conversation with TKNO & Healthcare Basket Updates

Citrini&CRDO
July 15, 2024

In Conversation: Credo Semiconductor

Our Conversation with Dan O’Neil of CRDO

Citrini&TetraTech
June 18, 2024

In Conversation: Tetra Tech Inc.

Our discussion with the CEO on the science, scale, and software of the water ecosystem, plus more on competition and the fiscal outlook.

Join our newsletter